Featured ArticlesPsoriasis

Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature

By August 27, 2020No Comments

Featured Article

Featured Article

The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popularization of a variety of cannabinoid preparations including topical forms such as creams, salves, lotions, lubricants, and many others.

Read more

This report details a case of a young man with psoriasis managed with topical cannabinoids.

Adam J. Friedman MD, Kimia Momeni BS, Mikhail Kogan MD

 

The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popularization of a variety of cannabinoid preparations including topical forms such as creams, salves, lotions, lubricants, and many others.

However, while the market is exponentially growing, the rate at which mechanistic and clinical evidence supporting the use of cannabinoids in a litany of diseases is significantly slower. In fact, Robinson et al highlighted significant gaps in dermatologists understanding of the biology of cannabinoids and comfort with this space, further highlighting the great need to disseminate information throughout the medical community.

Along this vein, we present a case of a young man with psoriasis managed with topical cannabinoids.

View Case Study Now
Article Cited in this Post

You May Also Like

A Study of Glabellar Contraction Patterns in African Descendants

| Aesthetics, Featured Articles, The Latest | No Comments
Glabellar Contraction Patterns in Black Patients: Implications for Botulinum Toxin Treatment Botulinum toxin is widely used for treating dynamic glabellar lines, but contraction patterns in Black patients had not been…
Journal of Drugs in Dermatology JDD Article About Gene Analysis of Biostimulators: Poly-L-Lactic Acid Triggers Regeneration While Calcium Hydroxylapatite Induces Inflammation Upon Facial Injection.

Gene Analysis of Biostimulators: Poly-L-Lactic Acid Triggers Regeneration While Calcium Hydroxylapatite Induces Inflammation Upon Facial Injection

| Aesthetics, Featured Articles, The Latest | No Comments
Comparing Biostimulatory Agents for Skin Rejuvenation Injectable biostimulators like poly-L-lactic acid (PLLA-SCA™) and calcium hydroxylapatite (CaHA-R) are used to stimulate collagen production in aging skin, but their molecular effects differ.…
Journal of Drugs in Dermatology JDD Article About Assessing the Landscape of AI-Powered Patient Documentation in Dermatology.

Assessing the Landscape of AI-Powered Patient Documentation in Dermatology

| Featured Articles, Social and Technology | No Comments
AI-Powered Documentation: A Burnout Solution for Dermatologists Burnout among US dermatologists has surged to 49% in 2023, with administrative tasks like charting and paperwork driving professional fatigue. AI-powered patient documentation…

Leave a Reply